Through co-expression of PD-1, CTLA-4, and PD-L1, melanoma cells are able to inhibit antigen presenting cells such as DCs by direct binding of CD80 and CD86 through CTLA-4 and by engagement of PD-L1 through PD-1. Here, CTLA4 is linked to melanoma.